Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $708667.0.

  • Immucell's Depreciation & Amortization (CF) rose 331.52% to $708667.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 106.08%. This contributed to the annual value of $2.7 million for FY2024, which is 35.67% down from last year.
  • According to the latest figures from Q3 2025, Immucell's Depreciation & Amortization (CF) is $708667.0, which was up 331.52% from $679037.0 recorded in Q2 2025.
  • In the past 5 years, Immucell's Depreciation & Amortization (CF) registered a high of $709098.0 during Q3 2023, and its lowest value of $603161.0 during Q4 2021.
  • In the last 5 years, Immucell's Depreciation & Amortization (CF) had a median value of $677500.0 in 2024 and averaged $658324.5.
  • In the last 5 years, Immucell's Depreciation & Amortization (CF) skyrocketed by 1300.04% in 2023 and then crashed by 326.77% in 2024.
  • Immucell's Depreciation & Amortization (CF) (Quarter) stood at $603161.0 in 2021, then grew by 0.5% to $606174.0 in 2022, then rose by 13.0% to $684979.0 in 2023, then dropped by 0.05% to $684655.0 in 2024, then increased by 3.51% to $708667.0 in 2025.
  • Its last three reported values are $708667.0 in Q3 2025, $679037.0 for Q2 2025, and $686773.0 during Q1 2025.